Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11926665 Methods of treating cancer with anti-TIM-3 antibodies

Patent 11926665 was granted and assigned to Tesaro on March, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Tesaro
Tesaro
0
Date Filed
January 9, 2018
0
Date of Patent
March 12, 2024
0
Patent Applicant
Tesaro
Tesaro
0
Patent Application Number
16476534
0
Patent Citations
‌
US Patent 8168757 PD-1 binding proteins
0
‌
US Patent 8481021 IL-1F5 polypeptides
0
‌
US Patent 8552156 Anti-TIM-3 antibody
0
‌
US Patent 8568992 Antibody categorization based on binding characteristics
0
‌
US Patent 8841418 Antibodies that specifically bind to TIM3
0
‌
US Patent 8871192 IL-1F8 polypeptides
0
‌
US Patent 9023995 Anti IL-36R antibodies
0
‌
US Patent 10472419 Antibody molecules to TIM-3 and uses thereof
0
‌
US Patent 10508149 Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)
0
‌
US Patent 11352427 Antibodies directed against T Cell immunoglobulin and mucin protein 3 (TIM-3)
0
•••
Patent Inventor Names
Andrew R. Ferguson
0
Dmitri Bobilev
0
Jing Wang
0
Kristen Anne McEachern
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11926665
0
Patent Primary Examiner
‌
Stephen L. Rawlings
0
CPC Code
‌
A61K 2039/505
0

Find more entities like US Patent 11926665 Methods of treating cancer with anti-TIM-3 antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.